234 Church Street, New Haven, CT 06510
Rallybio was founded in January 2018 with a mission to identify and accelerate the development of life-transforming therapies for patients with severe and rare diseases.
Rallybio became a public company on July 29, 2021.
December 31
Rallybio’s stock is traded on The NASDAQ Global Market under the symbol “RLYB”.
Rallybio does not currently, nor do we expect to declare or pay any cash or other dividends on our common stock in the foreseeable future.
Please email investors@rallybio.com.
To be added to Rallybio’s email distribution list, please visit the Investors website and sign up for email alerts.
You can visit the Financial Information page in the Investors section of our website. SEC filings can also be accessed from the SEC at www.sec.gov.
Computershare is our stock transfer agent. For questions regarding your shares, certificates, and other share-specific information, please contact Computershare in one of several ways:
Website: www.computershare.com
Telephone Inquiries:
1-800-736-3001, option 1 (U.S.)
1-781-575-3100, option 1 (non-U.S.)
Email Inquiries: web.queries@computershare.com
Written Requests:
By Mail:
Computershare
P.O. Box 505000
Louisville, KY 40233-5000
By Overnight Delivery:
Computershare
462 South 4th Street, Suite 1600
Louisville, KY 40202
Contact our transfer agent Computershare: www.computershare.com
Rallybio does not currently offer a direct stock purchase plan.